Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Current Assets (2016 - 2025)

Phibro Animal Health has reported Current Assets over the past 13 years, most recently at $862.2 million for Q4 2025.

  • Quarterly results put Current Assets at $862.2 million for Q4 2025, up 15.55% from a year ago — trailing twelve months through Dec 2025 was $862.2 million (up 15.55% YoY), and the annual figure for FY2025 was $810.6 million, up 34.88%.
  • Current Assets for Q4 2025 was $862.2 million at Phibro Animal Health, up from $835.8 million in the prior quarter.
  • Over the last five years, Current Assets for PAHC hit a ceiling of $862.2 million in Q4 2025 and a floor of $471.7 million in Q1 2021.
  • Median Current Assets over the past 5 years was $585.0 million (2023), compared with a mean of $619.2 million.
  • Biggest five-year swings in Current Assets: dropped 2.34% in 2024 and later skyrocketed 46.43% in 2025.
  • Phibro Animal Health's Current Assets stood at $508.6 million in 2021, then increased by 14.37% to $581.7 million in 2022, then increased by 0.84% to $586.6 million in 2023, then grew by 27.2% to $746.2 million in 2024, then rose by 15.55% to $862.2 million in 2025.
  • The last three reported values for Current Assets were $862.2 million (Q4 2025), $835.8 million (Q3 2025), and $810.6 million (Q2 2025) per Business Quant data.